Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature
Jan Kazenwadel(South Australia Pathology), Natasha L. Harvey(South Australia Pathology), Conrad V. Fernandez(Dalhousie University), Marshall S. Horwitz(University of Washington), Hamish S. Scott(South Australia Pathology), Robert S. Wildin(University of Vermont Medical Center), Jennifer Cuellar‐Rodríguez(National Institutes of Health), Genevieve A. Secker(South Australia Pathology), Milena Babic(South Australia Pathology), Yajuan J. Liu(Kaiser Permanente), Sarah Dyack(Dalhousie University), Akiko Shimamura(Harvard University), Dennis D. Hickstein(Immune Deficiency Foundation), Jill A. Rosenfeld(Baylor College of Medicine), Michael Y. Zhang(Fred Hutch Cancer Center), Steven M. Holland(National Institute of Allergy and Infectious Diseases), Christopher N Hahn(South Australia Pathology), Tom Walsh(University of Washington), Chan‐Eng Chong(Cancer Research Malaysia), Peter Bardy(Royal Adelaide Hospital), Amy P. Hsu(National Institute of Allergy and Infectious Diseases)
Cited by 280
Related Papers
Activated STING in a Vascular and Pulmonary Syndrome
|New England Journal of Medicine|2014|1.4k
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
|Nature|2008|1.1k
Neonatal-Onset Multisystem Inflammatory Disease Responsive to Interleukin-1β Inhibition
|New England Journal of Medicine|2006|902
Neutrophil Elastase, Proteinase 3, and Cathepsin G as Therapeutic Targets in Human Diseases
|Pharmacological Reviews|2010|857